Images List Premium Download Classic

Obesity

Obesity-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Substituted bridged urea analogs as sirtuin modulators
Glaxosmithkline Llc
February 15, 2018 - N°20180044338

Provided herein are novel substituted bridged urea and related analogs and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, ...
Vascular calcification prevention and treatment
Summit Innovation Labs Llc
February 15, 2018 - N°20180042962

The invention encompasses compositions and methods for effectively interfering, reducing and preventing conversion of vascular smooth muscle cells (vsmcs) and circulating stem cells to osteoblastic bone-like cells, thereby reducing and/or preventing vascular calcification (vc) or calcium mineral (hydroxyapatite) deposition in the vasculature. The severity and extent of calcification in the major arteries reflect atherosclerotic plaque burden and strongly predict ...
Metabolic syndrome treatment
Arkay Therapeutics, Llc
February 15, 2018 - N°20180042945

Formulations and methods of providing an orally-active anti-metabolic disease fixed dose combinations (fdc) for use as personalized medicine to treat different components of the metabolic syndrome or insulin resistance syndrome such as type ii diabetes, hypertension, hyperlipidemia and obesity are disclosed. Pharmaceutical compositions of anti-inflammatory centric drug formulations and methods comprising of nsaids in general and selective cox-2 inhibitors in ...
Obesity Patent Pack
Download 316+ patent application PDFs
Obesity Patent Applications
Download 316+ Obesity-related PDFs
For professional research & prior art discovery
inventor
  • 316+ full patent PDF documents of Obesity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Treatment and prevention of diabetes and obesity
February 15, 2018 - N°20180042287

Since the present compositions are aimed toward normalizing metabolism and energy expenditure and managing oxidative stress and inflammation, they are also beneficial in relation to physical activity, in particular performance, endurance, fatigue and recovery during intensive and continuous exercise/exertion.
Oxadiazolopyridine derivates for use as ghrelin o-acyl transferase (goat) inhibitors
February 08, 2018 - N°20180037594

Wherein the groups r1, r2 and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin o-acyl transferase (goat) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.
Substituted quinolines as pde-10 inhibitors
Sunovion Pharmaceuticals Inc.
February 08, 2018 - N°20180037590

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as cns disorders and metabolic disorders, including, but not limited to, e. G., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.
Obesity Patent Pack
Download 316+ patent application PDFs
Obesity Patent Applications
Download 316+ Obesity-related PDFs
For professional research & prior art discovery
inventor
  • 316+ full patent PDF documents of Obesity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for treating metabolic disorders using fgf
Salk Institute For Biological Studies
February 08, 2018 - N°20180036377

The method provides methods and compositions for treating metabolic disorders such as impaired glucose tolerance, elevated blood glucose, insulin resistance, dyslipidemia, obesity, and fatty liver.
Dermatopontin as a therapeutic for metabolic disorders
Agency For Science, Technology And Research
February 08, 2018 - N°20180036371

The present disclosure describes to a method of treating a metabolic disease in a subject, wherein the method comprises administration of dermatopontin to a subject, wherein the dermatopontin is recombinant dermatopontin and the metabolic disease is selected from a group consisting of weight gain, diet-induced weight gain, obesity, morbid obesity, metabolic syndrome, glucose homeostasis, insulin resistance, type i diabetes, type ...
Devices, solutions and methods for sample collection related applications, analysis and diagnosis
Abogen, Inc.
February 01, 2018 - N°20180031543

A solution is described for preserving cells and/or extra-cellular components in naturally expressed bodily fluids (e. G. Saliva, sputum, urine) for further downstream analysis and/or for diagnosis of a medical condition. The solution may be hypertonic with respect to blood. Techniques are described for enriching cells from a sample of a naturally expressed bodily fluid, and/or for ...
Mixture of purified sods of plant origin
Bionov
February 01, 2018 - N°20180030421

The present invention relates to an original and specific mixture of purified superoxide dismutases (sods) of plant origin, characterised in that said mixture is essentially made up of three superoxide dismutases: a manganese superoxide dismutase, a copper and zinc superoxide dismutase and an iron superoxide dismutase provided in two isoforms, which can be obtained from an extract of the hybrid ...
Compositions and methods for treating fatty tissue buildup
Mhs Care-innovation Llc
February 01, 2018 - N°20180030133

The present disclosure is directed to the treatment of diseases or conditions involving the buildup of fatty tissues, such as obesity, metabolic syndrome, type ii diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight gain and a marked decrease in lipid synthesis and accumulation.
Apelin fusion proteins and uses thereof
Regeneron Pharmaceuticals, Inc.
February 01, 2018 - N°20180030099

The invention provides a fusion protein or polypeptide comprising an apelin peptide fused to a multimerizing component. The invention also provides a fusion protein or polypeptide comprising an apelin peptide fused to an fc domain, a fragment of an fc domain, or a variant of an fc domain. Apelin fc-fusion polypeptides are capable of binding to the apelin receptor (aplnr). ...
Compositions and methods for treating obesity and hyperphagia
Mhs Care-innovation Llc
February 01, 2018 - N°20180028618

The present disclosure is directed to the treatment of diseases or conditions characterized by the buildup of fatty tissue, or hyperphagia, such as prader-willi syndrome, obesity, metabolic syndrome, type ii diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight gain, weight loss, and/or reduction in ...
Obesity Patent Pack
Download 316+ patent application PDFs
Obesity Patent Applications
Download 316+ Obesity-related PDFs
For professional research & prior art discovery
inventor
  • 316+ full patent PDF documents of Obesity-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
New York University
February 01, 2018 - N°20180028576

The present invention relates to characterizing changes in mammalian bacterial gastrointestinal, cutaneous and nasal microbiota associated with antibiotic treatment and various disease conditions (such as asthma, allergy, obesity, metabolic syndrome, gastrointestinal reflux disease (gerd), eosinophilic esophagitis, gastro-esophageal junction adenocarcinomas (gejac), infections due to bacteria that are resistant to antibiotics, including methicillin-resistant staphylococcus aureus (mrsa), clostridium difficile, vancomycin-resistant enterococci, etc.) and ...
Contact area diffusion factor for quantifying fat contents of liquid
January 25, 2018 - N°20180027214

A method for determining the presence of fats in the body fluid by photographing a body fluid droplet and calculating the change of the contact area of the body fluid droplet and the contact area diffusion factor. In addition, fats may be easily detected by using a simple filming equipment where it is required to detect fats such as liposuctions, ...
Screening method for compound having obesity preventive or therapeutic activity
January 25, 2018 - N°20180023087

To provide a screening method for a substance having an anti-obesity action and an anti-obesity drug. A screening method including: a step for contacting a test substance and a synoviolin-gene-expressing cell; and a step for verifying the effect of the test substance on the synoviolin gene expression, or the effect thereof on synoviolin protein activity. An action which reduces the ...
Bifidobacteria for treating diabetes and related conditions
Dupont Nutrition Biosciences Aps
January 25, 2018 - N°20180021391

This invention relates to new uses of bifidobacteria (particularly, although not exclusively, probiotic bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis ...
Acylated glucagon analogues
Novo Nordisk A/s
January 18, 2018 - N°20180016319

The present invention relates to novel peptide compounds which have an improved physical stability in solution and improved solubility at neutral ph, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the ...
Methods of treating an overweight or obese subject
Zafgen, Inc.
January 18, 2018 - N°20180016249

The disclosure herein generally relates to methods of treating an overweight or obese condition, and overweight- or obesity-related conditions. In one embodiment, the disclosure provides a method of treating an overweight or obese condition involving administering to the subject in need thereof, an amount of a pharmaceutical composition including a metap-2 inhibitory compound, or a salt, ester, or prodrug thereof, ...
Chemical ablation and method of treatment for various diseases
Neurotronic, Inc.
January 18, 2018 - N°20180015264

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue, in embodiments of the present invention, the formulation may ...
Drug for inhibiting adipose cell differentiation and insulin resistance
Beijing Protgen Ltd.
January 18, 2018 - N°20180015148

The present invention provides use of endostatin or a functional variant thereof in the preparation of a medicament for treating dietary obesity, non-alcoholic fatty liver disease, insulin resistance or glucose intolerance. In the embodiments of the present invention, the functional variant may be yh-16, mes, myh-16, m003, m007, mz101, or the like.
Loading